Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Non-Current Assets (2022 - 2026)

HeartSciences' Non-Current Assets history spans 5 years, with the latest figure at $2.5 million for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 18.35% year-over-year to $2.5 million; the TTM value through Jan 2026 reached $8.7 million, up 3.57%, while the annual FY2025 figure was $2.1 million, 4.55% down from the prior year.
  • Non-Current Assets reached $2.5 million in Q1 2026 per HSCS's latest filing, up from $2.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.5 million in Q1 2026 to a low of $130793.0 in Q3 2022.
  • Average Non-Current Assets over 5 years is $1.4 million, with a median of $2.0 million recorded in 2025.
  • The largest YoY upside for Non-Current Assets was 334.83% in 2023 against a maximum downside of 13.6% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $643706.0 in 2022, then decreased by 13.6% to $556147.0 in 2023, then soared by 275.47% to $2.1 million in 2024, then grew by 5.48% to $2.2 million in 2025, then grew by 11.49% to $2.5 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Non-Current Assets are $2.5 million (Q1 2026), $2.2 million (Q4 2025), and $2.0 million (Q3 2025).